Furthermore, Reparixin inhibited the F. nucleatum-mediated promotion of CT26-Luc cell metastasis in vivo, suggesting that F. nucleatum promotes CRC liver metastasis in vivo through IL-8 (Fig. 4C, D). The gene discussed is CXCL8; the disease is colorectal carcinoma.